---
name: AustinPx
slug: austinpx
site: cdmo
website_domain: austinpx.com
summary: Fee-for-service CDMO specializing in preclinical through Phase II formulation development and GMP manufacturing of oral dosage forms, with proprietary KinetiSol amorphous solid dispersion technology for poorly soluble APIs. Headquartered in Georgetown, United States.
tagline: Formulation and manufacturing CDMO for poorly soluble oral drugs, preclinical through Phase II.
founded_year: 2007
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: US
tier2_domain_verified: false
updated_at: 2026-09-22T07:02:42.285Z
services_count: 2
modalities_count: 1
indications_count: 0
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# AustinPx

Formulation and manufacturing CDMO for poorly soluble oral drugs, preclinical through Phase II.

Listed on cdmo.directory.

## Summary

Fee-for-service CDMO specializing in preclinical through Phase II formulation development and GMP manufacturing of oral dosage forms, with proprietary KinetiSol amorphous solid dispersion technology for poorly soluble APIs. Headquartered in Georgetown, United States.

## At a glance

- Founded: 2007
- HQ country: US

## Services

- Analytical Method Development & Validation
- ICH Stability Studies

## Modalities

- Small Molecule

## Locations

- Headquarters, Georgetown, TX, USA

## Long description

AustinPx is a fee-for-service CDMO founded in 2007, based in Georgetown, Texas. The company specializes in formulation development, analytical services, and GMP manufacturing of oral dosage forms from preclinical through Phase II clinical stages.

**Core Capabilities:**
- Preclinical development and formulation development
- Analytical method development and characterization
- GMP manufacturing for oral formulations and dose forms
- Bioavailability enhancement strategies
- Speed-to-clinic and market development strategies

**Proprietary Technology:**
AustinPx is the inventor of KinetiSol™ Technology, a next-generation amorphous solid dispersion (ASD) platform designed for poorly soluble active pharmaceutical ingredients. The technology offers a smaller footprint, broader design space, and greener processing solutions compared to conventional ASD approaches. The company can supply KinetiSol drug product intermediate (DPI) through commercial manufacturing.

**Service Scope:**
The cGMP facility can supply oral formulations and dose forms for preclinical testing, GLP toxicology studies, and Phase I/II clinical studies. The company emphasizes a data-driven, technology-agnostic approach where formulation strategy is tailored to the unique physicochemical characteristics of each molecule and client goals. AustinPx positions itself as client-centric, with flexible and responsive systems designed for the fast-paced early development environment.

## Related companies

- [Biopharma Technology LLC](/companies/btllc) (Analytical Method Development & Validation, ICH Stability Studies) — [Compare](/compare/austinpx/btllc)
- [ResolveMass Laboratories Inc.](/companies/resolvemass) (Analytical Method Development & Validation, Small Molecule) — [Compare](/compare/austinpx/resolvemass)
- [Thermo Fisher Scientific](/companies/thermofisher) (Analytical Method Development & Validation, ICH Stability Studies) — [Compare](/compare/austinpx/thermofisher)
- [Boston Institute of Biotechnology, LLC](/companies/bostonbib) (Analytical Method Development & Validation, ICH Stability Studies) — [Compare](/compare/austinpx/bostonbib)
- [Eurofins Central Laboratory](/companies/eurofins) (Analytical Method Development & Validation, ICH Stability Studies) — [Compare](/compare/austinpx/eurofins)
- [ProBioGen AG](/companies/probiogen) (Analytical Method Development & Validation, ICH Stability Studies) — [Compare](/compare/austinpx/probiogen)
- [ARSI Canada Inc](/companies/arsicanada) (Analytical Method Development & Validation, Small Molecule) — [Compare](/compare/arsicanada/austinpx)
- [Altasciences](/companies/altasciences) (Analytical Method Development & Validation, ICH Stability Studies) — [Compare](/compare/altasciences/austinpx)

_Profile last updated: 2026-09-22T07:02:42.285Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.